Literature DB >> 19702526

Clonidine in perioperative medicine and intensive care unit: more than an anti-hypertensive drug.

C Gregoretti1, B Moglia, P Pelosi, P Navalesi.   

Abstract

Clonidine is classified as an imidazoline and it is the prototypical alpha-2 receptor agonists. It has been used for several years to treat hypertension. It has also been used, "off label", for a variety of purposes, including opioid and anesthetic sparing effects, anxiolysis and sedation, drug withdrawal as well as stabilizing blood pressure and reducing stress response to surgery. Particularly in the case of patients with overt or underlying cardiac disease and in those at risk of perioperative ischemia the action of clonidine can be expected to reduce the risk of procedure-related cardiac events. In addition, clonidine used as a premedication drug before surgery or surgical procedure, has been shown to substantially reduce anaesthetic, benzodiazepine and opioids requirements. However, its "off label" use, the absence of an intravenous form of in the United States, possible inadvertent hypotension, bradycardia or post-operative sedation, and the variability of the haemodynamic response to different doses or rates of administration, have limited its use in clinical practice. This review discusses the potential role of clonidine and the supporting evidence for the use of this drug beyond its anti-hypertensive use in perioperative medicine and critical care in adults patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19702526     DOI: 10.2174/138945009788982478

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  11 in total

Review 1.  Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients.

Authors:  Ken Chen; Zhijun Lu; Yi Chun Xin; Yong Cai; Yi Chen; Shu Ming Pan
Journal:  Cochrane Database Syst Rev       Date:  2015-01-06

Review 2.  Pharmacological and nonpharmacological management of delirium in critically ill patients.

Authors:  Dustin M Hipp; E Wesley Ely
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 3.  Analgesic synergy between opioid and α2 -adrenoceptors.

Authors:  A-J Chabot-Doré; D J Schuster; L S Stone; G L Wilcox
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 4.  Clonidine for sedation and analgesia for neonates receiving mechanical ventilation.

Authors:  Olga Romantsik; Maria Grazia Calevo; Elisabeth Norman; Matteo Bruschettini
Journal:  Cochrane Database Syst Rev       Date:  2017-05-10

5.  Protein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs.

Authors:  Daniel J Schuster; Kelley F Kitto; Aaron C Overland; Robert O Messing; Laura S Stone; Carolyn A Fairbanks; George L Wilcox
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

6.  A novel approach to hyperemesis gravidarum: evaluation by a visual analogue scale score and treatment with transdermal clonidine.

Authors:  Aldo Maina; Tullia Todros
Journal:  Obstet Med       Date:  2011-11-22

7.  The comparative evaluation of intravenous with intramuscular clonidine for suppression of hemodynamic changes in laparoscopic cholecystectomy.

Authors:  Meena Singh; Arin Choudhury; Manpreet Kaur; Dootika Liddle; Mary Verghese; Ira Balakrishnan
Journal:  Saudi J Anaesth       Date:  2013-04

8.  Clonidine for pain in non-ventilated infants.

Authors:  Olga Romantsik; Maria Grazia Calevo; Elisabeth Norman; Matteo Bruschettini
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

9.  Control of hypertension in the critically ill: a pathophysiological approach.

Authors:  Diamantino Ribeiro Salgado; Eliezer Silva; Jean-Louis Vincent
Journal:  Ann Intensive Care       Date:  2013-06-27       Impact factor: 6.925

10.  Efficacy of lignocaine with clonidine and adrenaline in minor oral surgical procedure.

Authors:  Shouvik Chowdhury; Madhumati Singh; Anjan Shah
Journal:  Contemp Clin Dent       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.